Donald A. Berry
University of Texas M.D. Anderson Cancer Center
Houston
TX 77030
USA
Name/email consistency: high
- High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. Berry, D.A., Broadwater, G., Klein, J.P., Antman, K., Aisner, J., Bitran, J., Costanza, M., Freytes, C.O., Stadtmauer, E., Gale, R.P., Henderson, I.C., Lazarus, H.M., McCarthy, P.L., Norton, L., Parnes, H., Pecora, A., Perry, M.C., Rowlings, P., Spitzer, G., Horowitz, M.M. J. Clin. Oncol. (2002)
- HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer. Berry, D.A., Muss, H.B., Thor, A.D., Dressler, L., Liu, E.T., Broadwater, G., Budman, D.R., Henderson, I.C., Barcos, M., Hayes, D., Norton, L. J. Clin. Oncol. (2000)